Table 2.
Baseline characteristics by Triglyceride quartiles
| Characteristics | Triglyceride quartiles | P-value* | |||
|---|---|---|---|---|---|
| Q1 (<80.2mg/dL) | Q2 (80.2–110.8mg/dL) | Q3 (110.9–157.4mg/dL) | Q4 ( 157.5mg/dL) | ||
| Age, Median (IQR) | 56(51–61) | 57(52–62) | 57(53–62) | 57(53–62) | <0.01 |
| Race | |||||
| White | 2250(66.3) | 2461(73.4) | 2673(78.8) | 2882(86.3) | <0.01 |
| Gender | |||||
| Female | 2012(59.3) | 1940(57.9) | 1875(55.3) | 1666(49.9) | <0.01 |
| Center | |||||
| Forsyth County NC | 789(23.2) | 867(25.9) | 896(26.4) | 906(27.1) | <0.01 |
| Jackson, MS | 1003(29.5) | 778(23.2) | 632(18.6) | 410(12.3) | |
| Minneapolis, MN | 915(27.0) | 884(26.4) | 915(27.0) | 930(27.8) | |
| Washington County, MD | 688(20.3) | 822(24.5) | 949(28.0) | 1094(32.8) | |
| Smoking status | |||||
| Current cigarette smoker | 673(19.9) | 751(22.5) | 777(22.9) | 767(23.0) | <0.01 |
| Former cigarette smoker | 1215(35.8) | 1242(37.1) | 1287(38.0) | 1371(41.1) | |
| Never smoked cigarettes | 1503(44.3) | 1351(40.4) | 1325(39.1) | 1196(35.9) | |
| BMI (kg/m2), Median (IQR) | 25.5(22.9–28.7) | 26.7(23.8–30.2) | 27.5(24.9–31.0) | 28.6(25.8–31.9) | <0.01 |
| Education | |||||
| 12 years or more | 2719(80.2) | 2589(77.4) | 2658(78.6) | 2631(78.8) | 0.05 |
| Medications | |||||
| Cholesterol lowering medication including Statins | 139(4.1) | 158(4.7) | 231(6.8) | 334(10.0) | <0.01 |
| Steroids | 43(1.3) | 51(1.5) | 43(1.3) | 45(1.4) | 0.78 |
| Antineoplastic agents | 17(0.5) | 17(0.5) | 22(0.7) | 22(0.7) | 0.73 |
| Comorbidities | |||||
| Hypertension | 950(28.1) | 1089(32.6) | 1243(36.7) | 1464(44.0) | <0.01 |
| Diabetes | 229(6.8) | 333(10.0) | 480(14.2) | 777(23.3) | <0.01 |
| COPD | 1(0.03) | 4(0.12) | 2(0.06) | 3(0.09) | 0.56 |
| Patients with comorbiditiesτ | 1055(31.2) | 1239(37.2) | 1455(43.0) | 1769(53.2) | <0.01 |
| eGFR (mL/min/1.73m2), Median (IQR) | 99.8(91.4–108.9) | 97.8(88.8–105.8) | 96.3(87.3–104.3) | 95.8(86.6–103.3) | <0.01 |
| Hs-CRP (mg/dL) )ξ, Median (IQR) | 1.54(0.74–3.51) | 2.04(0.98–4.35) | 2.51(1.22–5.21) | 2.82(1.45–5.75) | <0.01 |
*
Chi-square tests were used for categorical variables and Wilcoxon rank-sum tests were applied for continuous variables.
ξ
hsCRP collected in total N=12,601 (pneumonia event yes N=1805, no N=10796)
τ
Patients with comorbidities include patients with at least 1 comorbid condition